Nuveen Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,183
| Closed | -$1.04M | – | 3328 |
|
|
2024
Q3 | $1.04M | Sell |
22,183
-497
| -2% | -$23.3K | ﹤0.01% | 2741 |
|
|
2024
Q2 | $1.22M | Sell |
22,680
-6,823
| -23% | -$369K | ﹤0.01% | 2627 |
|
|
2024
Q1 | $2.01M | Buy |
29,503
+2,541
| +9% | +$173K | ﹤0.01% | 2402 |
|
|
2023
Q4 | $1.69M | Sell |
26,962
-11,847
| -31% | -$742K | ﹤0.01% | 2489 |
|
|
2023
Q3 | $1.76M | Buy |
38,809
+920
| +2% | +$41.8K | ﹤0.01% | 2348 |
|
|
2023
Q2 | $2.13M | Buy |
+37,889
| New | +$2.13M | ﹤0.01% | 2308 |
|
|
2021
Q4 | – | Sell |
-138,987
| Closed | -$15.6M | – | 3322 |
|
|
2021
Q3 | $15.6M | Buy |
138,987
+6,596
| +5% | +$738K | ﹤0.01% | 1448 |
|
|
2021
Q2 | $21.4M | Buy |
132,391
+25,001
| +23% | +$4.05M | 0.01% | 1314 |
|
|
2021
Q1 | $13.1M | Buy |
107,390
+90
| +0.1% | +$11K | ﹤0.01% | 1625 |
|
|
2020
Q4 | $16.4M | Buy |
107,300
+42,370
| +65% | +$6.49M | 0.01% | 1373 |
|
|
2020
Q3 | $5.43M | Buy |
64,930
+45,231
| +230% | +$3.78M | ﹤0.01% | 1868 |
|
|
2020
Q2 | $1.45M | Sell |
19,699
-4,173
| -17% | -$307K | ﹤0.01% | 2464 |
|
|
2020
Q1 | $1.01M | Sell |
23,872
-7,949
| -25% | -$337K | ﹤0.01% | 2509 |
|
|
2019
Q4 | $1.94M | Sell |
31,821
-495
| -2% | -$30.1K | ﹤0.01% | 2428 |
|
|
2019
Q3 | $1.33M | Buy |
+32,316
| New | +$1.33M | ﹤0.01% | 2572 |
|